טוען...
Sofosbuvir + velpatasvir + voxilaprevir for the treatment of hepatitis C infection
INTRODUCTION: Hepatitis C is a disease with a significant global impact. Over the last several years, the treatment of the disease has been revolutionized. Therapy has transformed over the last several years with the approval of second generation direct acting antivirals, and currently utilized medi...
שמור ב:
| הוצא לאור ב: | Expert Opin Pharmacother |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6015630/ https://ncbi.nlm.nih.gov/pubmed/29634360 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14656566.2018.1459567 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|